Hello! Welcome to Greenpine Pharma Group Co.,Ltd. the official website!
PRODUCTS
Fusidic Acid Oral Suspension
1. In 1962, the Danish pharmaceutical company LEO developed fusidic acid, which has a unique structure and mechanism of action, no cross-resistance with other antibiotics, a very low rate of allergic reactions and good safety;
Classification:
Key words:
Fusidic Acid Oral Suspension
Message
Product Description
1. In 1962, the Danish pharmaceutical company LEO developed fusidic acid, which has a unique structure and mechanism of action, no cross-resistance with other antibiotics, a very low rate of allergic reactions and good safety;
2. Change the status quo of lack of specifications and dosage for children's medication, oral suspension designed specifically for children, exclusive dosage form, adjust the dosage according to the age of children;
3. Rapid and strong inhibition of G+ bacteria (especially MRSA) infection, is the preferred drug for children's respiratory tract, skin and soft tissue infections, fruit flavor, better drug compliance;
4. Strong tissue penetration, can reach the parts that blood can not reach, and at the same time has an anti-inflammatory effect, reduce the inflammatory damage caused by bacterial toxins;
5. Specification: 90ml: 4.5g, 30 boxes/ctn, imported from Denmark;
Previous Page
Next Page
Previous Page
Next Page
Related Products
Messages
If you are interested in our products, please leave your email, we will contact you as soon as possible, thank you!
Qingsong Pharmaceutical Group Co., Ltd.